NSE IPO - Apply Online, Check Issue Date, Price, Lot Size & Allotment Status

Apply for NSE IPO:

Skip to main content

Live Anixa Biosciences, Inc. Share Price Chart

O H L

Anixa Biosciences, Inc. Performance Overview

Days Range
$2.69Low
$2.75High

Markets Today

Previous Close$2.76
Open$2.75
Volume77,062
Day's Range$2.69 - $2.75
52W Range$2.32 - $5.46
Market Cap$90.39 M

Historical Performance

1M Returns-19.53
3M Returns-5.15
6M Returns-0.36
1Y Returns-18.10
5Y Returns-43.67
10Y ReturnsNA

Anixa Biosciences, Inc. Fundamentals

Market Cap$90.39 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTM-0.62
EPS TTM$-0.31
Quarterly Earnings Growth YOYN/A
PB Ratio6.21
EBITDA$-11.70 M
Profit MarginN/A
Market Cap$90.39 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTM-0.62
EPS TTM$-0.31
Quarterly Earnings Growth YOYN/A
PB Ratio6.21
EBITDA$-11.70 M
Profit MarginN/A

Anixa Biosciences, Inc. Profit & Loss

Apr 2025Jul 2025Oct 2025Jan 2026Apr 2026Jul 2026
Total Revenue +$0$0$0$0$0$0
Gross Profit +$0$0$0$0$0$0
Operating Income -$3.00 M-$2.44 M-$2.88 M-$2.72 M-$2.65 M-$2.74 M
EBITDA -$3.00 M-$2.44 M-$2.88 M-$2.72 M-$2.65 M-$2.74 M
Interest Expense $0$0$0$0$0$0
Depreciation $0$0$0$0$0$0
Income Before Tax -$2.81 M-$2.28 M-$2.72 M-$2.58 M-$2.54 M-$2.63 M
Income Tax Expense $0$0$0$0$0$0
Net Income +-$2.81 M-$2.28 M-$2.72 M-$2.58 M-$2.54 M-$2.63 M
Net Profit Margin ------

Anixa Biosciences, Inc. Financials Balance Sheet In USD

Apr 2025Jul 2025Oct 2025Jan 2026Apr 2026Jul 2026
Share Capital $322.00 K$328.00 K$330.00 K$335.00 K$339.00 K$346.00 K
Reserve & Surplus -$246.72 M-$248.98 M-$251.68 M-$254.24 M-$256.76 M-$259.36 M
Non-Current Liabilities $184.00 K$174.00 K$163.00 K$151.00 K$140.00 K$128.00 K
Current Liabilities $1.89 M$2.07 M$1.97 M$1.24 M$1.50 M$1.75 M
Total Liabilities $2.07 M$2.24 M$2.13 M$1.39 M$1.64 M$1.87 M
Fixed Assets $0$0$0$0$0$0
Current Assets $16.77 M$17.45 M$15.89 M$15.05 M$14.69 M$14.91 M
Total Assets $16.98 M$17.65 M$16.08 M$15.23 M$14.87 M$15.07 M

Anixa Biosciences, Inc. Cash Flow

Apr 2025Jul 2025Oct 2025Jan 2026Apr 2026Jul 2026
Net Income -$2.81 M-$2.28 M-$2.72 M-$2.58 M-$2.54 M-$2.63 M
Operating Cash Flow -$1.50 M-$1.51 M-$1.25 M-$2.61 M-$1.74 M-$1.77 M
Investing Cash Flow $2.34 M-$833.00 K$654.00 K$1.23 M$422.00 K-$245.00 K
Financing Cash Flow $18.00 K$1.93 M$350.00 K$1.69 M$1.25 M$1.94 M
Change in Cash $857.00 K-$415.00 K-$251.00 K$303.00 K-$70.00 K-$79.00 K

Anixa Biosciences, Inc. Return Calculator

The Anixa Biosciences, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$5,408
Invested Amount$10,000
Est. Returns$-4,592
Invest in USA Stock Today

About Anixa Biosciences, Inc.

Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.

FAQs

Anixa Biosciences, Inc. (ANIX) share price as of September 18, 2026 is $2.65. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Anixa Biosciences, Inc. (ANIX) Share by opening an international trading account with Angel One.
Purchasing Anixa Biosciences, Inc. (ANIX) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Anixa Biosciences, Inc. (ANIX) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Anixa Biosciences, Inc. (ANIX) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Anixa Biosciences, Inc. on September 18, 2026, is $90.39 M.
Anixa Biosciences, Inc. operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in Anixa Biosciences, Inc. (ANIX) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91